MRNA
MRNA
NASDAQ · Biotechnology

Moderna Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$54.35
+5.81 (+11.97%)
As of May 9, 1:06 AM ET ·
Analyst Consensus
Hold
30
Analysts
Very High
Coverage
Buy 3 10%
Hold 21 70%
Sell 6 20%
Price Target
Analyst Price Target +175.0% upside
Low Target $89.97
Average Target $149.45
High Target $212.09
Current Price $54.35
Current
$54.35
Target
$149.45
$89.97 $149.45 avg $212.09
Scenario Analysis
Bear Case
$89.97
65.5%
Low target
Base Case
$149.45
+175.0%
Avg target
Bull Case
$212.09
+290.2%
High target
Risk/Reward
4.4x
Highly favorable
Price in Context
52-Week High
$59.55
-8.7% from high
52-Week Low
$22.28
+143.9% from low
50-Day SMA
$37.98
+43.1% vs SMA
200-Day SMA
$29.64
+83.4% vs SMA
RSI (14)
57.2
Neutral
Target vs 52W High
$149.45
+151.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%